|
WO2016123543A1
|
|
Method for treating schizophrenia comprising administering lurasidone
|
|
MX2015016494A
|
|
Methods of treatment and compositions with xanthine oxidase inhibitors.
|
|
WO2013149109A1
|
|
Colchicine formulations; methods of making; and methods of use thereof
|
|
WO2013090196A1
|
|
Combinations of azilsartan and chlorthalidone for treating hypertension black patients
|
|
WO2012134828A1
|
|
Methods for treating heartburn and/or preventing gastric bleeding or hemorrhage in patients receiving clopidogrel therapy
|
|
CA2812034A1
|
|
Methods for concomitant treatment of theophylline and febuxostat
|
|
BR112012032033A2
|
|
new modified release xanthine oxidoreductase inhibitor or xanthine oxidase inhibitor dosage forms
|
|
MX2012009600A
|
|
Methods for stabilizing joint damage in subjects using xanthine oxidoreductase inhibitors.
|
|
EP2435403A2
|
|
Thiocolchicine derivatives, method of making and methods of use thereof
|
|
EP2262786A2
|
|
Colchicine solid-state forms; methods of making; and methods of use thereof
|
|
EP2203068A1
|
|
Methods of treating gastrointestinal disorders independent of the intake of food
|
|
EP1401402A2
|
|
Enhancement of oral bioavailability of non-emulsified formulation of cefditoren pivoxil with lecithin
|
